In vivo detection of thalamic gliosis: A pathoradiologic demonstration in familial fatal insomnia

Archives of Neurology

Volumn 65, Issue 4, 2008, Pages 545-549

  Haïk, Stéphane ^a,b   Galanaud, Damien ^b   Linguraru, Marius G ^c   Peoc'h, Katell ^d   Privat, Nicolas ^a   Faucheux, Baptiste A ^a,b   Ayache, Nicholas ^c   Hauw, Jean Jacques ^b   Dormont, Didier ^b   Brandel, Jean Philippe ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INRIA   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE K;

ADULT; ANAMNESIS; ARTICLE; BRAIN REGION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FAMILIAL FATAL INSOMNIA; FAMILY HISTORY; FEMALE; GENE MUTATION; GLIOSIS; HUMAN; IN VIVO STUDY; INSOMNIA; MALE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRION DISEASE; PRIORITY JOURNAL; THALAMUS;

ALLELES; BRAIN; CODON; DEMENTIA; DIFFUSION MAGNETIC RESONANCE IMAGING; DNA MUTATIONAL ANALYSIS; GLIOSIS; HOMOZYGOTE; HUMANS; INSOMNIA, FATAL FAMILIAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHIONINE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; POLYSOMNOGRAPHY; PRIONS; THALAMIC DISEASES; THALAMUS;

EID: 42249099331     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.4.545     Document Type: Article

References (21)

1. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(5):577-583.
2. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease [erratum published in Lancet. 2000;356(9224):170. Colchester AF corrected to Colchester AC]. Lancet. 2000;355(9213):1412-1418.
3. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005;128(pt 9):2026-2033.
4. Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol. 2006;63(2):288-290.
5. Haïk S, Brandel JP, Salomon D, et al. Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology. 2004;63(12):2413-2415.
6. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol. 2003;2(3):167-176.
7. Nicoli F, Lefur Y, Denis B, Ranjeva JP, Confort-Gouny S, Cozzone PJ. Metabolic counterpart of decreased apparent diffusion coefficient during hyperacute ischemic stroke: a brain proton magnetic resonance spectroscopic imaging study [published online ahead of print June 19, 2003]. Stroke. 2003;34(7):e82-e87. doi:10.1161/01.STR.0000078659.43423.0A.
8. Galanaud D, Nicoli F, Chinot O, et al. Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med. 2006;55(6):1236-1245.
9. Galanaud D, Chinot O, Nicoli F, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg. 2003;98(2):269-276.
10. Hauw JJ, Sazdovitch V, Laplanche JL, et al. Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology. 2000;54(8):1641-1646.
11. Haïk S, Peoc'h K, Brandel JP, et al. Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation. Ann Neurol. 2004;56(6):909-910.
12. Perani D, Cortelli P, Lucignani G, et al. [18F]FDG PET in fatal familial insomnia: the functional effects of thalamic lesions. Neurology. 1993;43(12):2565-2569.
13. Parchi P, Castellani R, Cortelli P, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38(1):21-29.
14. Cortelli P, Perani D, Parchi P, et al. Cerebral metabolism in fatal familial insomnia: relation to duration, neuropathology, and distribution of protease-resistant prion protein. Neurology. 1997;49(1):126-133.
15. Haïk S, Dormont D, Faucheux BA, Marsault C, Hauw JJ. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol. 2002;51(6):797-799.
16. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol. 2002;59(1):128-134.
17. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63(3):443-449.
18. Chung YL, Williams A, Ritchie D, et al. Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport. 1999;10(17):3471-3477.
19. Sadowski M, Tang CY, Aguinaldo JG, Carp R, Meeker HC, Wisniewski T. In vivo micro magnetic resonance imaging signal changes in scrapie infected mice. Neurosci Lett. 2003;345(1):1-4.
20. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26(6):1551-1562.
21. Vidal C, Meric P, Provost F, et al. Preclinical metabolic changes in mouse prion diseases detected by 1H-nuclear magnetic resonance spectroscopy. Neuroreport. 2006;17(1):89-93.